Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nectar Lifesciences
Chandigarh, Chandigarh, Indianeclife.com ↗
- Ownership
- Private
- Employees
- ~1686
- Development stage
- Other
01
Overview
Nectar Lifesciences has a global commercial presence with approvals from major regulatory agencies including the US, EU, Japan, Brazil, Mexico and South Africa. The company manufactures APIs and finished dosage forms of cephalosporin antibiotics as well as menthol derivatives. It also offers diagnostic equipment and patient care devices. Its generics division covers over 300 SKUs with pan India distribution. No clinical-stage pipeline; all products are commercial.
- Therapeutic areas
- EndocrinologyInfectious DiseasesOther
- Modalities
- Small moleculeBiologic (limited; mainly small molecules/antibiotics)Device (diagnostics and patient care devices)
- Industry
- Contract Manufacturing Organization
02
Partnerships
Not specifically disclosed; acts as CMO to global pharma innovators.
Beyond the preview
Go deeper on Nectar Lifesciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nectar Lifesciences.